Jump to content
RemedySpot.com

Tobira's new drug TBR-652 blocks both CCR5 and CCR2

Rate this topic


Guest guest

Recommended Posts

Guest guest

Yeah, but they failed to mention that bringing HIV viral load down also lowers inflammation. They should compare their drug to Maraviroc and measure inflammatory markers.Also, people in the audience reminded the presenters that blocking CCR2 may also increase cancer rates (in mice) http://www.hivandhepatitis.com/2010_conference/AIDS2010/docs/0802a_2010.htmlRegards, VergelPoWeRUSA.org

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...